Summary
Since the early 1980s, when the first transgenic mice were generated, thousands of genetically modified mouse lines have been created. Early on, Jaenisch established proof of principle, showing that viral integration into the mouse genome and germline transmission of those exogenous sequences were possible (Proc Natl Acad Sci USA 71:1250–1254, 1974). Gordon et al. (Proc Natl Acad Sci USA 77:7380–7384, 1980) and Brinster et al. (Cell 27:223–231, 1981) subsequently used cloned genes to create “transgenic constructs” in which the exogenous DNA was randomly inserted into different sites in the mouse genome, stably maintained, and transmitted through the germline to the progeny. The utility of the process quickly became apparent when a transgene carrying the metallothionein-1 (Mt-1) promoter linked to thymidine kinase was able to drive expression in the mouse liver when promoter activity was induced by administration of metals. In an attempt to find stronger and more reliable promoters, viral promoter elements from SV40 or cytomegalovirus were incorporated. However, while these promoters were able to drive high levels of expression, for many applications they proved to be too blunt an instrument as they drove ubiquitous expression in many, if not all cell types, making it very hard to discern organ-specific or cell-type-specific effects due to transgene expression. Thus the need to find cell-type-specific promoters that could reproducibly drive high levels of transgene expression in a particular cell type, e.g., cardiomyocyte, became apparent. One such example is the α myosin heavy-chain (MHC) promoter, which has been used extensively to drive transgene expression in a cardiomyocyte-specific manner in the mouse. This chapter, while not written as a typical methods section, will describe the necessary components of the α myosin promoter. In addition, common problems associated with transgenic mouse lines will be addressed.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Jaenisch, R. and Mintz, B. (1974) Simian virus 40 DNA sequences in DNA of healthy adult mice derived from preimplantation blastocysts injected with viral DNA. Proc Natl Acad Sci USA, 71, 1250–1254.
Gordon, J.W., Scangos, G.A., Plotkin, D.J., Barbosa, J.A. and Ruddle, F.H. (1980) Genetic transformation of mouse embryos by microinjection of purified DNA. Proc Natl Acad Sci USA, 77, 7380–7384.
Brinster, R.L., Chen, H.Y., Trumbauer, M., Senear, A.W., Warren, R. and Palmiter, R.D. (1981) Somatic expression of herpes thymidine kinase in mice following injection of a fusion gene into eggs. Cell, 27, 223–231.
Bronson, S.K., Plaehn, E.G., Kluckman, K.D., Hagaman, J.R., Maeda, N. and Smithies, O. (1996) Single-copy transgenic mice with chosen-site integration. Proc Natl Acad Sci USA, 93, 9067–9072.
Dupuy, A.J., Clark, K., Carlson, C.M., Fritz, S., Davidson, A.E., Markley, K.M., Finley, K., Fletcher, C.F., Ekker, S.C., Hackett, P.B. et al (2002) Mammalian germ-line transgenesis by transposition. Proc Natl Acad Sci USA, 99, 4495–4499.
Gulick, J., Subramaniam, A., Neumann, J. and Robbins, J. (1991) Isolation and characterization of the mouse cardiac myosin heavy chain genes. J Biol Chem, 266, 9180–9185.
Pedersen, A.G., Baldi, P., Chauvin, Y. and Brunak, S. (1999) The biology of eukaryotic promoter prediction – a review. Comput Chem, 23, 191–207.
Suzuki, Y., Tsunoda, T., Sese, J., Taira, H., Mizushima-Sugano, J., Hata, H., Ota, T., Isogai, T., Tanaka, T., Nakamura, Y. et al (2001) Identification and characterization of the potential promoter regions of 1031 kinds of human genes. Genome Res, 11, 677–684.
Proudfoot, N.J., Furger, A. and Dye, M.J. (2002) Integrating mRNA processing with transcription. Cell, 108, 501–512.
Reed, R. (2003) Coupling transcription, splicing and mRNA export. Curr Opin Cell Biol, 15, 326–331.
Kozak, M. (1987) An analysis of 5′-noncoding sequences from 699 vertebrate messenger RNAs. Nucleic Acids Res, 15, 8125–8148.
Marano, R.J., Brankov, M. and Rakoczy, P.E. (2004) Discovery of a novel control element within the 5′-untranslated region of the vascular endothelial growth factor. Regulation of expression using sense oligonucleotides. J Biol Chem, 279, 37808–37814.
Lai, E.C. (2002) Micro RNAs are complementary to 3′ UTR sequence motifs that mediate negative post-transcriptional regulation. Nat Genet, 30, 363–364.
Knouff, C., Malloy, S., Wilder, J., Altenburg, M.K. and Maeda, N. (2001) Doubling expression of the low density lipoprotein receptor by truncation of the 3′-untranslated region sequence ameliorates type iii hyperlipoproteinemia in mice expressing the human apoe2 isoform. J Biol Chem, 276, 3856–3862.
McNeish, J.D., Thayer, J., Walling, K., Sulik, K.K., Potter, S.S. and Scott, W.J. (1990) Phenotypic characterization of the transgenic mouse insertional mutation, legless. J Exp Zool, 253, 151–162.
Lerman, I., Harrison, B.C., Freeman, K., Hewett, T.E., Allen, D.L., Robbins, J. and Leinwand, L.A. (2002) Genetic variability in forced and voluntary endurance exercise performance in seven inbred mouse strains. J Appl Physiol, 92, 2245–2255.
Rajagopal, S.K., Ma, Q., Obler, D., Shen, J., Manichaikul, A., Tomita-Mitchell, A., Boardman, K., Briggs, C., Garg, V., Srivastava, D. et al (2007) Spectrum of heart disease associated with murine and human GATA4 mutation. J Mol Cell Cardiol, 43, 677–685.
Sekar, R.B., Kizana, E., Smith, R.R., Barth, A.S., Zhang, Y., Marban, E. and Tung, L. (2007) Lentiviral vector-mediated expression of GFP or Kir2.1 alters the electrophysiology of neonatal rat ventricular myocytes without inducing cytotoxicity. Am J Physiol Heart Circ Physiol, 293, H2757–H2770.
Buerger, A., Rozhitskaya, O., Sherwood, M.C., Dorfman, A.L., Bisping, E., Abel, E.D., Pu, W.T., Izumo, S. and Jay, P.Y. (2006) Dilated cardiomyopathy resulting from high-level myocardial expression of Cre-recombinase. J Card Fail, 12, 392–398.
McCloskey, D.T., Turnbull, L., Swigart, P.M., Zambon, A.C., Turcato, S., Joho, S., Grossman, W., Conklin, B.R., Simpson, P.C. and Baker, A.J. (2005) Cardiac transgenesis with the tetracycline transactivator changes myocardial function and gene expression. Physiol Genomics, 22, 118–126.
Sanbe, A., Gulick, J., Hanks, M.C., Liang, Q., Osinska, H. and Robbins, J. (2003) Reengineering inducible cardiac-specific transgenesis with an attenuated myosin heavy chain promoter. Circ Res, 92, 609–616.
Maue, R.A. (2007) Understanding ion channel biology using epitope tags: progress, pitfalls, and promise. J Cell Physiol, 213, 618–625.
Weng, A., Magnuson, T. and Storb, U. (1995) Strain-specific transgene methylation occurs early in mouse development and can be recapitulated in embryonic stem cells. Development, 121, 2853–2859.
Boyes, J. and Bird, A. (1991) DNA methylation inhibits transcription indirectly via a methyl-CpG binding protein. Cell, 64, 1123–1134.
Gundersen, G., Kolsto, A.B., Larsen, F. and Prydz, H. (1992) Tissue-specific methylation of a CpG island in transgenic mice. Gene, 113, 207–214.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2009 Humana Press, a part of Springer Science+Business Media, LLC
About this protocol
Cite this protocol
Gulick, J., Robbins, J. (2009). Cell-Type-Specific Transgenesis in the Mouse. In: Cartwright, E. (eds) Transgenesis Techniques. Methods in Molecular Biology, vol 561. Humana Press. https://doi.org/10.1007/978-1-60327-019-9_6
Download citation
DOI: https://doi.org/10.1007/978-1-60327-019-9_6
Published:
Publisher Name: Humana Press
Print ISBN: 978-1-60327-018-2
Online ISBN: 978-1-60327-019-9
eBook Packages: Springer Protocols